Oral microbiota of patients with phenylketonuria: A nation-based cross-sectional study/Experiment 14
From BugSigDB
Subjects
- Location of subjects
- Germany
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Mouth Adult mouth,Cavital oralis,Cavitas oris,Cavum oris,Mouth cavity,Oral region,Oral vestibule,Regio oralis,Rima oris,Stoma,Stomatodaeum,Trophic apparatus,Vestibule of mouth,Vestibulum oris,Mouth,mouth
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Phenylketonuria Folling disease,Folling's disease,Folling's syndrome,Følling's disease,HPA, non-PKU mild,hyperphenylalaninemia, non-PKU mild,imbecilitus phenylpyruvica,oligophrenia Phenylpyruvica,oligophrenia phenylpyruvica,PAH deficiency,Pah deficiency,pah deficiency,Phenylalanine hydroxylase deficiency,phenylalanine hydroxylase deficiency,phenylalaninemia,phenylketonuria,phenylketonuria, maternal,phenylpyruvic oligophrenia,PKU,Phenylketonuria
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Phenylketonuria Ch (PKU-S)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Ch (PKU-SP)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Children diagnosed with Phenylketonuria (PKU) and who stimulated Subgingival plaque samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 59
- Group 1 sample size Number of subjects in the case (exposed) group
- 51
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- N/A
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V1-V2
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Signature 1
Source: Figure 2(D)
Description: Differential abundant genera in PKU Saliva and PKU Subgingival plague Children samples
Abundance in Group 1: increased abundance in Phenylketonuria Ch (PKU-SP)
| NCBI | Quality Control | Links |
|---|---|---|
| Alloprevotella | ||
| Atopobium | ||
| Gemella | ||
| Haemophilus | ||
| Lachnoanaerobaculum | ||
| Neisseria | ||
| Peptostreptococcus | ||
| Porphyromonas | ||
| Prevotella | ||
| Streptococcus | ||
| Veillonella |
Revision editor(s): MyleeeA
Signature 2
Source: Figure 2(D)
Description: Differential abundant genera in PKU Saliva and PKU Subgingival plague Adult samples
Abundance in Group 1: decreased abundance in Phenylketonuria Ch (PKU-SP)
| NCBI | Quality Control | Links |
|---|---|---|
| Campylobacter | ||
| Tannerella | ||
| Peptococcus | ||
| Olsenella | ||
| Cardiobacterium | ||
| Actinomyces | ||
| Selenomonas | ||
| FO332FO332 | ||
| Kingella | ||
| Fretibacterium | ||
| Corynebacterium | ||
| Fusobacterium | ||
| Capnocytophaga | ||
| Arachnia |
Revision editor(s): MyleeeA
